Symbol
TRAW on Nasdaq
Investment type
Equity / Common stock, par value $.01 per share
Latest Disclosed Shares Owned
760,824 shares
Security Ownership %
20%
Shares, Excluding Options vs Price
Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW)

29 Jan 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 760,824 shares of Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW). This represents 20% ownership of the company. This is the first filing by ORBIMED ADVISORS LLC disclosing ownership of Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.